Medicines for human use under evaluation 2014–2012

Monthly lists of medicines for human use under evaluation by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) from 2014–2012 are available on this page.

The CHMP meets once per month. All monthly lists of medicines that were under evaluation by the CHMP can be found in this section, dating back to March 2012.

Monthly lists 2014

Applications for new human medicines under evaluation by the CHMP: December 2014

Reference Number: EMA/759365/2014Summary:

This document lists information on applications for centralised marketing authorisation for human

medicines that the European Medicines Agency has received for evaluation. It includes the international

non-proprietary names (INN) and therapeutic areas for all new innovative medicines under evaluation

by the Committee for Medicinal Products for Human Use (CHMP).

Applications for new human medicines under evaluation by the CHMP: November 2014

Reference Number: EMA/682555/2014Summary:

This document lists information on applications for centralised marketing authorisation for human

medicines that the European Medicines Agency has received for evaluation.

Applications for new human medicines under evaluation by the CHMP: October 2014

Reference Number: EMA/614184/2014Summary:

This document lists information on applications for centralised marketing authorisation for human medicines that the European Medicines Agency has received for evaluation.

.

Applications for new human medicines under evaluation by the CHMP: September 2014

Reference Number: EMA/545907/2014Summary:

This document lists information on applications for centralised marketing authorisation for human

medicines that the European Medicines Agency has received for evaluation.

Applications for new human medicines under evaluation by the CHMP: August 2014

Reference Number: EMA/465005/2014

Applications for new human medicines under evaluation by the CHMP: July 2014

Reference Number: EMA/411381/2014Summary:

This document lists information on applications for centralised marketing authorisation for human

medicines that the European Medicines Agency has received for evaluation. It includes the international

non-proprietary names (INN) and therapeutic areas for all new innovative medicines under evaluation by the Committee for Medicinal Products for Human Use (CHMP).

Applications for new human medicines under evaluation by the CHMP: June 2014

Reference Number: EMA/349630/2014

Applications for new human medicines under evaluation by the CHMP: May 2014

Reference Number: EMA/284861/2014

Applications for new human medicines under evaluation by the CHMP: April 2014

Reference Number: EMA/237058/2014

Applications for new human medicines under evaluation by the CHMP: March 2014

Reference Number: EMA/145689/2014Summary:

This document lists information on applications for centralised marketing authorisation for human medicines that the European Medicines Agency has received for evaluation.

Applications for new human medicines under evaluation by the CHMP: February 2014

Reference Number: EMA/71695/2014

Applications for new human medicines under evaluation by the CHMP: January 2014

Reference Number: EMA/21080/2014

Monthly lists 2013

Applications for new human medicines under evaluation by the CHMP: December 2013

Reference Number: EMA/773850/2013Summary:

This document lists information on applications for centralised marketing authorisation for human medicines that the European Medicines Agency has received for evaluation.

Applications for new human medicines under evaluation by the CHMP: November 2013

Reference Number: EMA/693057/2013Summary:

This document lists information on applications for centralised marketing authorisation for human medicines that the European Medicines Agency has received for evaluation.

Applications for new human medicines under evaluation by the CHMP: October 2013

Reference Number: EMA/641348/2013 Corr

Applications for new human medicines under evaluation by the CHMP: September 2013

Reference Number: EMA/544684/2013

Applications for new human medicines under evaluation by the CHMP: August 2013

Reference Number: EMA/472391/2013Summary:

This document lists information on applications for centralised marketing authorisation for human

medicines that the European Medicines Agency has received for evaluation. It includes the international

non-proprietary names (INN) and therapeutic areas for all new innovative medicines under evaluation

by the Committee for Medicinal Products for Human Use (CHMP). For generic and biosimilar medicines,

it includes the INN (active moiety only, with no information on salt, ester or derivative) and

therapeutic area.

Applications for new human medicines under evaluation by the CHMP: July 2013

Reference Number: EMA/406711/2013Summary:

This document lists information on applications for centralised marketing authorisation for human

medicines that the European Medicines Agency has received for evaluation. It includes the international

non-proprietary names (INN) and therapeutic areas for all new innovative medicines under evaluation

by the Committee for Medicinal Products for Human Use (CHMP). For generic and biosimilar medicines,

it includes the INN (active moiety only, with no information on salt, ester or derivative) and

therapeutic area.

Applications for new human medicines under evaluation by the CHMP: June 2013

Reference Number: EMA/358707/2013

Applications for new human medicines under evaluation by the CHMP: May 2013

Reference Number: EMA/284501/2013

Applications for new human medicines under evaluation by the CHMP: April 2013

Reference Number: EMA/224612/2013

Applications for new human medicines under evaluation by the CHMP: March 2013

Reference Number: EMA/192989/2013

Applications for new human medicines under evaluation by the CHMP: February 2013

Reference Number: EMA/100806/2013

Applications for new human medicines under evaluation by the CHMP: January 2013

Reference Number: EMA/21316/2013Summary:

This document lists information on applications for centralised marketing authorisation for human

medicines that the European Medicines Agency has received for evaluation. It includes the international

non-proprietary names (INN) and therapeutic areas for all new innovative medicines under evaluation

by the Committee for Medicinal Products for Human Use (CHMP).

Monthly lists 2012

Applications for new human medicines under evaluation by the CHMP: December 2012

Reference Number: EMA/767392/2012

Applications for new human medicines under evaluation by the CHMP: November 2012

Reference Number: EMA/712937/2012

Applications for new human medicines under evaluation by the CHMP: October 2012

Reference Number: EMA/648405/2012Summary:

This document lists information on applications for centralised marketing authorisation for human

medicines that the European Medicines Agency has received for evaluation.

Applications for new human medicines under evaluation by the CHMP: September 2012

Reference Number: EMA/584368/2012

Applications for new human medicines under evaluation by the CHMP: August 2012

Reference Number: EMA/507407/2012

Applications for new human medicines under evaluation by the CHMP: July 2012

Reference Number: EMA/454567/2012

Applications for new human medicines under evaluation by the CHMP: June 2012

Reference Number: EMA/362726/2012

Applications for new human medicines under evaluation by the CHMP: May 2012

Reference Number: EMA/293765/2012

Applications for new human medicines under evaluation by the CHMP: April 2012

Reference Number: EMA/208936/2012

Applications for new human medicines under evaluation by the CHMP: March 2012

Reference Number: EMA/152848/2012